What's new at Łukasiewicz – PORT?
- Reading time: 3 min.
A delegation of senior leadership from Łukasiewicz – PORT visited Dresden and Leipzig to strengthen collaboration with leading life sciences institutions in Saxony, focusing on biobanking, precision medicine, novel therapies, and cross-border R&D opportunities.
- Reading time: 3 min.
For decades, we viewed tumors as autonomous aggressors – isolated masses of mutated cells. Today, we know that picture is incomplete. Tumors send signals, form connections, and actively shape their surroundings.
- Reading time: 3 min.
Leading scientists, clinicians, industry representatives, working at the intersection of oncology, neuroscience, and precision medicine will meet at Łukasiewicz – PORT on May 28–29, 2026.
- Reading time: 3 min.
Dr. Andrii Domanskyi, a neurobiologist with years of academic and industry experience, will discuss chronic pain research on April 16 at 2:00 PM in the Main Hall of Łukasiewicz – PORT.
- Reading time: 3 min.
Project selection procedures, Poland’s innovation convergence with the EU, and plans for a Shared Services Center were the key topics discussed at the March 20 meeting of the Łukasiewicz Research Network Directors in Wrocław.
- Reading time: 3 min.
Can cancer cells exploit strategies known from parasite biology? Dr. Marek Wagner explores melanoma from an evolutionary perspective, highlighting how tumors may manipulate the immune system in ways reminiscent of parasites.
- Reading time: 3 min.
For more than a century, science believed that neurons were responsible for our thoughts, emotions, and memory. During Brain Awareness Week, we tell the story of astrocytes.
- Reading time: 3 min.
The WABIO Project has secured over PLN 7 million under the TEAM NET program to develop and validate an integrated biorefinery prototype within the consortium. The work at Łukasiewicz will be led by Prof. Andrzej Białowiec.
- Reading time: 2 min.
We invite you to join a free webinar titled “European Innovation Pathways in Health: Opportunities for MedTech and Biotech Companies,” dedicated to growth and funding opportunities for companies operating in the medical technology and biotechnology sectors.
- Reading time: 3 min.
On February 24, at the headquarters of the Foundation for Polish Science, we officially launched the implementation of the International Research Agendas (MAB) project within the P4Health Center of Excellence.
- Events
